# FDA Inspection 1305102 - Biomat USA Inc - February 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9c762485-74f1-42dd-8369-77e7bf297882
Source feed: FDA_Inspections

> FDA Inspection 1305102 for Biomat USA Inc on February 09, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305102
- Company Name: Biomat USA Inc
- Inspection Date: 2026-02-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1305102 - 2026-02-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b7d7daad-3b20-4ba6-aae8-270bd84b708a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/26b1aabc-48c2-41bb-9b95-1c51dca9d75a